-

Chicago Court Upholds $45 Million Mesothelioma Verdict Against Johnson & Johnson

Dean Omar Branham Shirley represents family of deceased woman

CHICAGO--(BUSINESS WIRE)--A Circuit Court in Cook County, Ill., has denied a request by Johnson & Johnson (NYSE:JNJ) for a new trial in a mesothelioma lawsuit decided in April, upholding a jury verdict and award of $45 million in the asbestos-related death of a mother of six.

Johnson & Johnson raised multiple issues in its motion for a new trial, but in each case, the court either found for the plaintiff or determined that any issue did not substantially prejudice the jury.

The decision from Judge Patrick J. Sherlock means the jury’s verdict in the case filed by the children of Theresa Garcia will stand.

“We are happy that the court saw through Johnson & Johnson’s bag of tricks,” said Trey Branham of Dean Omar Branham Shirley, LLP, the firm representing the Garcia family. “Johnson & Johnson and its subsidiaries tried for years to delay this trial, all the while knowing that their powder contained asbestos.”

During trial, the jury heard testimony indicating Ms. Garcia’s lifelong use of Johnson & Johnson’s talc-based Baby Powder resulted in mesothelioma, an always-fatal cancer in the lining of the lungs. She was diagnosed in January 2020 and died in July of that year.

Laboratory testing has shown the presence of asbestos in many samples of Johnson’s Baby Powder.

“Johnson & Johnson deceived its customers for years rather than owning up to its negligence,” said partner Jessica Dean, who also represents Ms. Garcia’s family. “It's truly shameless.”

Ms. Garcia is survived by her children Stephanie Salcedo, Vanessa Garcia, Edward Cerda, Jr., Jazmine Cerda, Caressa Garcia and Anyssa Cerda.

The case is Stephanie Salcedo et al., vs Cyprus Amax Minerals Company, et al., Case No. 2020 L 004505 in Circuit Court in Cook County, Illinois.

Dean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of the irresponsible conduct of others. For more information, visit www.dobslegal.com.

Contacts

BeLynn Hollers
800-559-4534
Belynn@androvett.com

Dean Omar Branham Shirley, LLP


Release Versions

Contacts

BeLynn Hollers
800-559-4534
Belynn@androvett.com

More News From Dean Omar Branham Shirley, LLP

DOBS National Asbestos Trial Team Earns Super Lawyers Honors

DALLAS--(BUSINESS WIRE)--Five attorneys with Dean Omar Branham Shirley, LLP (DOBS), a nationally recognized trial firm with a track record of coast-to-coast verdicts on behalf of mesothelioma victims, have earned selection to the 2026 Super Lawyers and Rising Stars lists. Partners Trey Branham, Kathy Farinas and Cori Kapusta, along with attorney Darren McDowell, were selected to Super Lawyers, a distinction awarded to the top 5% of attorneys in each state. Attorney Anthony Bianco was named to t...

Firm-Record Nine Dean Omar Branham Shirley Attorneys Recognized for Plaintiff Consumer Law Excellence

DALLAS--(BUSINESS WIRE)--In the wake of a record-breaking year on behalf of clients, nine attorneys with Dean Omar Branham Shirley (DOBS) have been named Lawdragon 500 Leading Plaintiff Consumer Lawyers for 2026. Name partners Jessica Dean, Amin Omar, Trey Branham and Lisa Shirley were selected for the Lawdragon list alongside partners Benjamin Braly, Aaron Chapman, Kathy Farinas, Cori Kapusta and Danny Kraft, of counsel. “Our increased representation on Lawdragon’s list recognizes the outstand...

California Appeals Court Upholds $51 Million Ruling Against Avon in Mesothelioma Case

LOS ANGELES--(BUSINESS WIRE)--The California 2nd District Court of Appeals has affirmed a $51 million verdict against Avon for causing the death of a California woman who developed the terminal cancer mesothelioma after years of exposure to asbestos contained in the multinational cosmetics company’s products. Plaintiff Rita-Ann Chapman passed away in March 2025, a little more than two years after the verdict against Avon was handed down. “Companies cannot ignore science, disregard their own int...
Back to Newsroom